智通财经APP讯，丽珠医药(01513)公布，截至 2025 年 3 月 31 日，公司通过集中竞价交易方式回购了公司 A 股股份共计约942.6万股，占公司总股本的比例为 1.03%，购买的最高价为人民币 38.37 元/股，最低价为人民币 35.18 元/股，已使用的资金总额为约人民币3.42亿元(不含交易费用)。
截至 2025 年 3 月 31 日，公司回购了公司 H 股股份共计724.53万股，占公司总股本的比例为 0.80%，购买的最高价为港币 27.80 元/股，最低价为港币 23.75元/股，已使用的资金总额为约港币1.91亿元(不含交易费用)。上述回购符合公司回购 H 股的一般授权。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.